AIM
ARRY

Assured Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Assured Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-265,267
Closed -$6.47M – 1103
2019
Q1 		$6.47M Buy
+265,267
New +$5.52M 0.07% 108
2018
Q3 		– Sell
-148,399
Closed -$2.49M – 1371
2018
Q2 		$2.49M Sell
148,399
-138,346
-48% -$2.2M 0.05% 370
2018
Q1 		$4.68M Buy
+286,745
New +$4.59M 0.11% 238

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assured Investment Management's ARRY Position: Q2 2019 in Review

Assured Investment Management sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 265,267 shares — an estimated $6.47M sold.

Assured Investment Management first reported a position in ARRY in Q1 2018 and held it in 3 quarters. The position peaked at $6.47M in Q1 2019. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Assured Investment Management reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 265,267 Array Biopharma Inc shares in Q2 2019, an estimated $6.47M.
  • Assured Investment Management first reported a position in Array Biopharma Inc in Q1 2018 and held it in 3 quarters.
  • Assured Investment Management's Array Biopharma Inc position peaked at $6.47M in Q1 2019.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.